Trump Reciprocal Tariffs: Indian Pharma shares may see positive reaction on tariff exemption for now

Share it

Currently, India charges a 10% tariff on Pharma imports from the US, while the US does not impose any tariff on imports of Indian pharmaceutical items.

Leave a Comment

Your email address will not be published. Required fields are marked *